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miR-208A Targeted Suppression of PDE4D Directly Enhances Myocyte
Contractile Function via PKA-Mediated Phosphorylation of cTnI and PLN
Fikru B. Bedada, Joseph M. Metzger.
University of Minnesota, St paul, MN, USA.
Molecular inotropy refers to cardiac myocyte contractile status that can be ti-
trated, positively or negatively, to affect overall heart pump performance. Al-
though inotropic drugs have been in clinical practice for many decades, there is
an urgent need to discover new inotropes with unique mechanisms of action for
the treatment of heart failure. Here, we investigate the prospect of micro-RNAs
to directly modify downstream inotropic signaling pathways for improving
contractile function. We focused on miR-208a owing in part to its known re-
stricted expression profile in the myocardium. Results show that acute miR-
208a expression, at 4-5 fold over endogenous miR-208a and independent of al-
tered host myosin gene expression, confers significant positive inotropy and
faster relaxation compared to miR-208a-mutant and untreated control adult car-
diac myocytes (P<0.05). Using in vitro cardiac stress testing, miR-208a ampli-
fied the inotropic and relaxation responses to increased stimulation frequency.
MiR-208a also promoted fast calcium transient decay with no change in peak
calcium accounting in part for enhanced relaxation. To gain insight into mech-
anism, we analyzed in silico putative miR-208a targets, focusing on potential
inotropic signaling targets. Interestingly, we provide evidence that miR-208a
has a direct effect to negatively regulate expression of PDE4D, but does not af-
fect PDE5A in myocytes. Consistent with these findings, phosphorylation of
cTnI and PLN at PKA sites was increased in myocytes after acute miR-208a
expression. Taken together, we show for the first time that miR-208a confers
positive inotropy and enhances relaxation in myocytes by PKA mediated phos-
phorylation of cTnI and PLN through a mechanism of direct suppression of
PDE4D. Because heart failure is associated with decreased phosphorylation
of cTnI and PLN, miR-208a may represent a new therapeutic modality for en-
hancing ventricular myocyte performance via the PDE4D-cAMP-PKA signal-
ing pathway.
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Regulatory Light Chain Phosphorylation Mimic S15D Causes Partial
Rescue of Isometric Force Production in FHC Causing Mutation D166V
William M. Schmidt1, Priya Muthu2, James Watt1, Jeffrey Moore1,
Danuta Szczesna-Cordary2.
1Boston University School of Medicine, Boston, MA, USA, 2University of
Miami Miller School of Medicine, Miami, FL, USA.
Familial hypertrophic cardiomyopathy (FHC) is characterized by a pathological
thickening of the muscle surrounding the heart and is the leading cause for sud-
den cardiac death in young people. There are numerous mutations in sarco-
meric proteins that have been implicated in causing FHC. Myosin, the
molecular motor that powers cardiac muscle contraction, consists of a globular
domain and an elongated a-helical neck region, which is thought to undergo
large conformational changes during muscle contraction. The myosin regula-
tory light chain (RLC) functions to support the neck region, therefore it is
not surprising that several single amino acid substitutions in the RLC have
been implicated in FHC.
Here we studied D166V, an RLC point mutation that is associated with in-
creased left ventricular wall thickness, abnormal electrocardiogram, and de-
creased isometric force and ATPase in skinned fibers from transgenic mouse
hearts. We have expressed porcine cardiac b myosin (the same isoform found
in humans) and replaced the endogenous RLC with a human RLC. The ex-
changed RLC contained either wild type (WT), D166V, S15A, or a double mu-
tant D166V/S15A, or D166V/S15D. The S15D mutation served as
a phosphorylation mimic. We performed frictional loading assays using a mod-
ified in vitromotility assay and determined the average force produced by a bed
of monomeric myosin. While maximal unloaded velocity was unchanged for all
of the mutants studied, the force of D166V and D166V/S15A was significantly
reduced compared to WT, with an additive decrease in the double mutant.
D166V/S15D resulted in a significant increase in force compared to D166V/
S15A and was restored to near WT levels. These results suggest that D166V
causes a reduction in myosin isometric force production and phosphorylation
may act to recover it.
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Physiological Effects of FHC-Causing K104E Mutation in the Myosin
Regulatory Light Chain
Wenrui Huang1, Katarzyna Kazmierczak1, Priya Muthu1, Yingcai Wang1,
Jingsheng Liang1, Ana I. Rojas1, Theodore P. Abraham2,
Danuta Szczesna-Cordary1.
1University of Miami, Miami, FL, USA, 2Johns Hopkins University,
Baltimore, MD, USA.We have studied the physiological effects of the Lysine 104 to Glutamic Acid
(K104E) mutation in the ventricular myosin regulatory light chain (RLC),
shown to cause familial hypertrophic cardiomyopathy (FHC). In vitro and in
vivo experiments were performed using transgenic (Tg) mouse cardiac muscle
preparations carrying the K104E-RLC mutation. We observed a slight but sig-
nificant decrease in maximal force (DFmaxy8kN/m
2) and an increase in the
Ca2þ-sensitivity (DpCa50y0.1) of isometric contraction in glycerinated
skinned muscle fibers from Tg-K104E compared to Tg-WT mice. No mutant
related changes in rigor binding of transgenic K104E mouse myosin to
pyrene-actin were observed. Likewise, no changes in actomyosin or myofibril-
lar ATPase activities were monitored. Histological examination of Masson’s
trichrome stained Tg-hearts showed signs of fibrosis in 8 mo-old Tg-K104E
mice compared to age matched Tg-WT. These observed changes in myocyte
organization in Tg-K104E mice could be due to ~4-fold decrease in the myosin
heavy chain-RLC interaction determined by the binding of bacterially ex-
pressed K104Emutant to RLC-depleted porcine myosin. Echocardiography ex-
amination of senescent Tg-K104E mice confirmed a hypetrophic phenotype
and showed a significantly enlarged interventricular septum and LVPWd
(left ventricular posterior wall in diasole), ~1.6-fold increase in LV mass and
significantly decreased LVIDs (LV inner diameter in systole) compared to
Tg-WT mice. However, EF (ejection fraction) was higher in Tg-K104E mice
(7358%) compared to 6157% observed in Tg-WTmice. In addition, Doppler
E velocity was also 1.3-fold higher in Tg-K104E mice compared to Tg-WT.
These results confirm a mutation induced hypertrophic phenotype in Tg-
K104E mice, similar to the patients carrying this FHC-mutation. No drastic
changes at the level of actomyosin interaction or in cardiac function assessed
in Tg-K104E mice suggest that the mutation might be associated with good
prognosis. Supported by NIH-HL071778 (DSC).
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Myosin Regulatory Light Chain Phosphorylation Rescues Cardiac
Dysfunction Caused by Familial Hypertrophic Cardiomyopathy-Linked
Mutations
Priya Muthu, Katarzyna Kazmierczak, Wenrui Huang, Ana I. Rojas,
Danuta Szczesna-Cordary.
University Of Miami: Miller School of Medicine, Miami, FL, USA.
In this report, we compared the role of cardiac myosin regulatory light chain
(RLC) phosphorylation on cardiac function in skinned muscle preparations
containing two RLC mutations, R58Q (arginine to glutamine) and D166V (as-
partic acid to valine), both linked with a malignant disease phenotype. Previous
studies on D166V-transgenic mice showed that the myosin light chain kinase
(MLCK)-induced phosphorylation of D166V mouse myocardium was able to
alleviate detrimental functional effects caused by this mutation. In this study,
we used recombinant phosphomimetic S15D (serine to aspartate) mutation in
the D166V background exchanged into porcine cardiac myosin and investi-
gated the effect of constitutively phosphorylated RLC proteins on the actomy-
osin interaction. The actin-activated myosin ATPase activity, which was
decreased in D166V- exchanged myosin, was partially rescued in S15D-
D166V exchanged myosin reaching the level observed for WT-reconstituted
myosin. Similarly, myosin reconstituted with S15D-D166V mutant showed
an increase in the binding to fluorescently labeled actin compared to D166V-
reconstituted myosin, with Kd=1.9 mM and Kd=41 mM, respectively. To further
investigate whether MLCK-phosphorylation could rescue the phenotype asso-
ciated with the R58Q mutation, we studied force development in transgenic
R58Q-mouse papillary muscle fibers. Compared to Tg-WT, a drastic reduction
in maximal force and myofibrillar ATPase activity was observed in samples
carrying the R58Q mutation. However, MLCK induced phosphorylation of
R58Q muscle fibers resulted in significantly increased maximal force and myo-
fibrillar ATPase activity. These results suggest that RLC phosphorylation plays
an important role not only in the physiological performance of the heart, but
also helps to maintain normal cardiac function in the diseased myocardium.
Our findings may contribute to the development of targeted cellular therapeutic
approaches to limit FHC related cardiac dysfunction. Supported by AHA-
10POST3420009 (PM) and NIH- HL071778 and HL090786 (DSC).
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Novel Phosphorylation Sites and Reduced Phosphorylation Levels in
Human Cardiac MyBP-C from Failing Hearts
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Anne M. Murphy1, Jennifer E. Van Eyk1.
1Johns Hopkins University, Baltimore, MD, USA, 2The University of
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Cardiac myosin binding protein-C (cMyBP-C) is a large multidomain protein
associated with the thick filaments. Phosphorylation of cMyBP-C is a regulator
of cardiac contractility and it is known that the phosphorylation status of
